Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly
Background: The higher effectiveness of MF59®-adjuvanted trivalent influenza vaccine
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …
Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly.
F Lapi, E Marconi, M Simonetti, V Baldo… - Expert Review of …, 2019 - europepmc.org
Background: The higher effectiveness of MF59®-adjuvanted trivalent influenza vaccine
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …
[PDF][PDF] Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly
F Lapi, E Marconi, M Simonetti, V Baldo, A Rossi… - 2019 - researchgate.net
Background: The higher effectiveness of MF59®-adjuvanted trivalent influenza vaccine
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …
Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly
F Lapi, E Marconi, M Simonetti… - Expert review of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background: The higher effectiveness of MF59®-adjuvanted trivalent influenza vaccine
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …
Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly.
F Lapi, E Marconi, M Simonetti, V Baldo, A Rossi… - 2019 - cabidigitallibrary.org
Background: The higher effectiveness of MF59®-adjuvanted trivalent influenza vaccine
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …
(MF59-TIV) vs. nonadjuvanted TIV in preventing influenza-related hospitalizations was …